EUVIMED · CrossrefZeitschrift
European Journal of Haematology
ISSN 0902-4441 · Wiley
Neueste Artikel
Issue Information
Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants
SKY92 Identifies High‐Risk Newly Diagnosed Multiple Myeloma With Inferior Progression‐Free Survival and Implicates NUF2 as a Candidate Driver
Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory m IDH1 AML
Hyperferritinemia: Pathophysiology, Etiologies, and Diagnostic Approach
Economic Burden of Chronic Lymphocytic Leukaemia in Australia
Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases
Navigating the Paradigm Shift in Chronic Lymphocytic Leukemia: Insights From EHA 2026
Thrombotic Microangiopathy‐Like Phenotype in Patients With Infection‐Associated Disseminated Intravascular Coagulation Treated With Thrombomodulin Alfa
Engineering Hematopoietic Immunity: The Next Evolution of Transplantation and Cellular Therapy
Trends in Global Anemia Prevalence Among Women of Reproductive Age, 2000–2023
Long‐Term Clinical Outcomes, Adherence, Persistence, and Adverse Event Management in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
Clonal Dynamics of GPI ‐Deficient Cells in Patients With Paroxysmal Nocturnal Hemoglobinuria ( PNH ): A Retrospective Follow‐Up Analysis
Underweight BMI Independently Predicts Inferior Survival in DLBCL Treated With R‐ CHOP : A Lymphoma Registry Study
A Phase IIa , Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof‐of‐Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease
Zero Confirmed Transmissions Require a Denominator
Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis
Cardiac Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With First‐Line Ibrutinib–Venetoclax
Bispecific Antibodies and T‐Cell Engagers in Multiple Myeloma
From Immune Dysfunction to Clinical Risk: Infections in Myelofibrosis
Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non‐Hodgkin Lymphoma on Reproduction Patterns
Diagnostic Accuracy of Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Differentiating Tumor and Bland Thrombus in Patients With Cancer: A Systematic Review and Meta‐Analysis
InflaMix Predicts Severe CRS , ICU Admission, and Progression‐Free Survival After CAR ‐T Therapy in LBCL
Extracellular Vesicle‐Based Approaches in Acute Myeloid Leukemia: Therapeutic Potential and Translational Challenges
Von Willebrand Factor and ADAMTS13 in Relation to Atherosclerosis in the General Population: The Rotterdam Study
Reduced Circulating Regulatory T Cells in Autoimmune and Chronic Idiopathic Neutropenia of Childhood: An Observational Study of Clinical and Laboratory Associations
Bone Marrow Fibrosis as a Predictor of Extramedullary Disease in Multiple Myeloma
Patient‐Reported Symptom Burden and Objective Responses After Belumosudil in Heavily Pretreated Chronic GvHD
Reply to: “Interpreting the Association Between Plasma Citrulline and Bloodstream Infection in Pediatric Acute Myeloid Leukemia”
Beyond Dendritic Cells: A Cellular Pharmacology Agenda for mRNA Cancer Vaccines in Hematologic Malignancies
Jahrgänge
2026 · 2542025 · 2052024 · 2142023 · 2202022 · 1632021 · 1922020 · 1792019 · 1602018 · 2002017 · 1802016 · 2002015 · 1882014 · 1822013 · 1752012 · 1582011 · 1752010 · 1892009 · 1862008 · 1802007 · 2072006 · 2082005 · 2302004 · 1702003 · 1912002 · 1322001 · 1482000 · 1431999 · 1301998 · 1371997 · 1321996 · 1841995 · 1581994 · 1351993 · 1361992 · 1281991 · 1511990 · 1741989 · 2381988 · 1831987 · 187
EUVIMED